Archean Chemical Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Archean Chemical Industries reported standalone revenue of Rs. 104,154 lakhs for FY26, up 2.7% from Rs. 101,379 lakhs in FY25. However, standalone profit after tax declined 13.8% to Rs. 5,589 lakhs from Rs. 6,484 lakhs. Consolidated PAT declined steeper at 32.3% to Rs. 4,169 lakhs from Rs. 6,162 lakhs. Q4 standalone PAT fell 47% year-on-year to Rs. 2,976 lakhs while Q4 consolidated PAT dropped 77% to Rs. 1,223 lakhs. The Board recommended a final dividend of Rs. 2.50 per share (125%). Statutory auditors PKF Sridhar & Santhanam LLP were reappointed for 4 years. An Income Tax Department search was conducted in September 2025 with notices received under Section 158BC. Exceptional item of Rs. 4,018 lakhs was recorded due to Asna cyclone damage to industrial salt stock. Current borrowings increased significantly to Rs. 20,317 lakhs from Rs. 853 lakhs in standalone results.
The company showed revenue growth but profit declined sharply, indicating margin compression and operational challenges. The significant jump in borrowings and ongoing tax department scrutiny are concerns. However, clean audit opinion and dividend recommendation provide some stability for investors.